TenNor Therapeutics Suzhou Ltd. Class H
HHKEX:6872101.70
HKD
+1.00
(+0.99%)
Share Statistics
As of December 31, 2025, TenNor Therapeutics Suzhou Ltd. Class H has 51.75M shares outstanding.
| Shares Outstanding | 51.75M |
Financial Position
As of December 31, 2025, TenNor Therapeutics Suzhou Ltd. Class H maintains a current ratio of 5.02, meaning it holds 5.0x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 5.02 |
| Quick Ratio | 4.82 |
| Debt / Equity | 18.62 |
Financial Efficiency
These figures cover the twelve months ended December 31, 2025.
| Employee Count | 54.00 |
Stock Price Statistics
HKDThese figures are as of the close on October 22, 2026.
| 50-Day Moving Average | 144.98 |
Balance Sheet
HKDAs of December 31, 2025, TenNor Therapeutics Suzhou Ltd. Class H holds 204.51M in cash and equivalents against 31.89M in total debt, resulting in a net debt position of -174.72M. Total book value stands at 171.23M, with working capital of 170.50M providing operational flexibility.
| Cash & Cash Equivalents | 204.51M |
| Total Debt | 31.89M |
| Net Debt | -174.72M |
| Equity (Book Value) | 171.23M |
| Book Value Per Share | 3.31 |
| Working Capital | 170.50M |
Cash Flow
HKDThese figures cover the twelve months ended December 31, 2025.
| Capital Expenditures | -45,628.52 |